Meeder Asset Management Inc Evolus, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 17, 2019	SELL	$13.91 - $19.87 $10,724 - $15,319	-771 Closed	0 $0
Q2 2019 Aug 05, 2019	SELL	$13.19 - $28.36 $12,675 - $27,253	-961 Reduced 55.48%	771 $11,000
Q1 2019 Apr 16, 2019	BUY	$12.43 - $28.91 $7,072 - $16,449	569 Added 48.93%	1,732 $39,000
Q4 2018 Jan 17, 2019	BUY	$10.57 - $19.29 $10,295 - $18,788	974 Added 515.34%	1,163 $14,000
Q3 2018 Nov 02, 2018	BUY	$17.31 - $29.82 $2,423 - $4,174	140 Added 285.71%	189 $0
Q2 2018 Jul 24, 2018	BUY	$6.85 - $38.49 $335 - $1,886	49 New	49 $0

169

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $658M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.